Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thymomas: clinical-pathological correlations.

M Lucchi1, F Basolo, A Ribechini

  • 1Unit of Thoracic Surgery, Cardiac and Thoracic Department, University of Pisa, Pisa, Italy. m.lucchi@med.unipi.it

The Journal of Cardiovascular Surgery
|January 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Graves' disease, thyroid autoantibodies and ultrasound features correlate with distinctive histological features.

Journal of endocrinological investigation·2023
Same author

MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.

Journal of endocrinological investigation·2023
Same author

Author Correction: Features of fragile people with SARS-CoV-2 infection in isolation in a COVID-19 hotel in Rome, Italy.

European review for medical and pharmacological sciences·2022
Same author

Features of fragile people with SARS-CoV-2 infection in isolation in a COVID-19 hotel in Rome, Italy.

European review for medical and pharmacological sciences·2022
Same author

Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response.

Journal of endocrinological investigation·2022
Same author

Role of the mononuclear cell infiltrate in Graves' orbitopathy (GO): results of a large cohort study.

Journal of endocrinological investigation·2021

The World Health Organization (WHO) histologic classification of thymoma correlates with thymus-related syndromes and Masaoka stage. However, it did not prove to be a prognostic factor for thymoma recurrence.

Area of Science:

  • Oncology
  • Pathology
  • Thoracic Surgery

Background:

  • The World Health Organization (WHO) histologic classification of thymoma was established in 1999.
  • Few studies have correlated this classification with clinical features and patient outcomes.
  • Thymoma treatment and prognosis are influenced by histologic subtype and clinical stage.

Purpose of the Study:

  • To retrospectively analyze thymoma patients to compare the WHO histologic classification with clinical behavior.
  • To evaluate the correlation between WHO histologic subtypes and clinical features, including thymus-related syndromes and tumor recurrence.
  • To assess the prognostic value of the WHO classification in thymoma.

Main Methods:

  • Retrospective analysis of 69 thymoma patients who underwent surgical treatment between 1983 and 1998.

Related Experiment Videos

  • Histologic typing of thymoma specimens according to the WHO classification.
  • Comparison of clinical features with histologic subtypes and survival analysis of prognostic factors.

    • Main Results:

    • Incidence of thymus-related syndromes increased progressively from WHO type A to B3.
    • Six intrathoracic recurrences (3 intrapleuric, 3 mediastinal) were observed over a mean follow-up of 108 months.
    • Actuarial five-year and ten-year survival rates were 95% and 88.9%, respectively. The WHO classification did not prove to be a prognostic factor for survival.

    Conclusions:

    • The WHO histologic classification appears to correlate with thymus-related syndromes and Masaoka clinical stage.
    • Despite a higher recurrence incidence in B3 and C subtypes, the WHO classification was not a significant prognostic factor for thymoma.
    • Further research may be needed to fully elucidate the prognostic implications of WHO histologic subtypes in thymoma.